The Antiviral Research is a research journal that publishes research related to Immunology and Microbiology; Pharmacology, Toxicology and Pharmaceutics. This journal is published by the Elsevier. The ISSN of this journal is 01663542, 18729096. Based on the Scopus data, the SCImago Journal Rank (SJR) of antiviral research is 1.701.
Also, please check the following important details about antiviral research: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
The latest Impact Factor list (JCR) is released in June 2024.
The Impact Factor of Antiviral Research is 4.5.
The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.
The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.
Journal Title: | Antiviral Research |
Publisher: | Elsevier |
ISSN: | 01663542, 18729096 |
Type: | journal |
Journal Scope: | Immunology and Microbiology; Pharmacology, Toxicology and Pharmaceutics |
Country: | Netherlands |
H-Index: | 144 |
SJR: | 1.701 |
Quartile: | Pharmacology (Q1); Virology (Q2) |
The antiviral research is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
The latest impact factor of antiviral research is 4.5 which is recently updated in June, 2024.
The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.
Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.
The latest Quartile of antiviral research is Q1.
Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.
The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.
The review time also depends upon the quality of the research paper.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to Immunology and Microbiology; Pharmacology, Toxicology and Pharmaceutics, then visit the official website of antiviral research and send your manuscript.
SIMILIAR JOURNALS
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
ISSN: 0892-3973FOOD AND AGRICULTURAL IMMUNOLOGY
ISSN: 0954-0105MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
ISSN: 1386-1964MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
ISSN: 1383-5718MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
ISSN: 1383-5742ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
ISSN: 0362-1642TOP RESEARCH JOURNALS